Robin L. Washington

2009

In 2009, Robin L. Washington earned a total compensation of $3.5M as Senior Vice President and Chief Financial Officer at Gilead Sciences, a 6% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$394,640
Option Awards$1,357,443
Salary$527,505
Stock Awards$1,237,871
Other$5,000
Total$3,522,459

Washington received $1.4M in option awards, accounting for 39% of the total pay in 2009.

Washington also received $394.6K in non-equity incentive plan, $527.5K in salary, $1.2M in stock awards and $5K in other compensation.

Rankings

In 2009, Robin L. Washington's compensation ranked 1,236th out of 9,885 executives tracked by ExecPay. In other words, Washington earned more than 87.5% of executives.

ClassificationRankingPercentile
All
1,236
out of 9,885
88th
Division
Manufacturing
437
out of 3,690
88th
Major group
Chemicals And Allied Products
93
out of 866
89th
Industry group
Drugs
61
out of 638
90th
Industry
Biological Products, Except Diagnostic Substances
7
out of 133
95th
Source: SEC filing on March 20, 2012.

Washington's colleagues

We found five more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2009.

2009

John Martin

Gilead Sciences

Chief Executive Officer

2009

John Milligan

Gilead Sciences

Chief Operating Officer

2009

Kevin Young

Gilead Sciences

Executive Vice President, Commercial Operations

2009

Norbert Bischofberger

Gilead Sciences

Chief Scientific Officer

2009

Gregg Alton

Gilead Sciences

Executive Vice President, Corporate and Medical Affairs

News

You may also like